Ketamine One Partners with Cognetivity Neurosciences in Collaborative Clinical Study on Depression and PTSD

KetamineOne Capital Limited announced that it is entering into a collaborative partnership with Cognetivity Neurosciences Ltd. to study and develop assessments for depression and post-traumatic stress disorder (PTSD).